CIK: 1896056 - Address: C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275, Fort Lee, NJ 07024
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/13/24 08:47
5/10/24
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP76.320101,493D
3/22/23 08:30
3/21/23
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP511.990001,362D
3/17/23 08:31
3/15/23
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP710.710101,362D
11/18/22 08:30
11/16/22
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP.m27.150001,245D
9/27/22 08:45
9/23/22
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP27.870001,245D
9/6/22 08:00
9/2/22
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP38.310001,245D
9/2/22 08:30
8/31/22
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP.m248.070301,244D
5/23/22 08:31
5/20/22
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP516.540001,241D
5/18/22 08:31
5/16/22
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP.m519.440001,241D
5/13/22 08:30
5/12/22
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP2015.850101,241D
2/8/22 18:00
2/4/22
NVCTNuvectis Pharma, Inc.DEHealthDrugPharmaceutical PreparationsShemesh ShayNJOChief DeP.m103.410301,180D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact